Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...

Jayden Wilsey was the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease after federal approval in 2024.

A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered ...

Sharpen your Mains answer-writing skills with GS-3 questions by following the thought process. Do not miss points to ponder ...

With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for ...

Click in for more news from The Hill {beacon} Health Care   The Big Story Senate on the cusp of ending shutdown The Senate is ...

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.

Given the success of the Research Topic ‘Diversity and Molecular Diagnostics of Fungi and Oomycetes in Plants’ Volume I and the rapidly evolving subject ...

For decades, statins like Lipitor and Zocor have been the cornerstone of cholesterol management. But as experts note, they ...

Intellia Therapeutics (NTLA), a clinical-stage biotechnology company, saw its shares plunge more than 22% on Friday, Nov. 7, after management acknowledged a patient’s death in a gene-editing study for ...

Using genomics, evolutionary biologists test several hypotheses on the origin of viruses. New evidence suggests they may have ...